Portal de Periódicos da CAPES

Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil

2011; Wiley; Volume: 18; Issue: 12 Linguagem: Inglês

10.1111/j.1468-1331.2011.03513.x

1468-1331

Susanne Pirker, Christoph Baumgartner,

Epilepsy research and treatment

European Journal of NeurologyVolume 18, Issue 12 p. e151-e151 LETTER TO THE EDITOR Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil S. Pirker, S. Pirker 2nd Neurological Department, General Hospital Hietzing, Vienna, AustriaSearch for more papers by this authorC. Baumgartner, C. Baumgartner 2nd Neurological Department, General Hospital Hietzing, Vienna, AustriaSearch for more papers by this author S. Pirker, S. Pirker 2nd Neurological Department, General Hospital Hietzing, Vienna, AustriaSearch for more papers by this authorC. Baumgartner, C. Baumgartner 2nd Neurological Department, General Hospital Hietzing, Vienna, AustriaSearch for more papers by this author First published: 18 November 2011 https://doi.org/10.1111/j.1468-1331.2011.03513.xCitations: 17 Christoph Baumgartner, MD, 2nd Neurological Department, General Hospital Hietzing with Neurological Center Rosenhügel and Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology, Riedelgasse 5, 1130 Vienna, Austria (tel.: +43 1 88000 266; fax: +43 1 88000 384; e-mail: [email protected]). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Löscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005; 6: 591– 602. 2 Summers MA, Moore JL, McAuley JW. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Ann Pharmacother 2004; 38: 1631– 1634. 3 Iannetti P, Spalice A, Parisi P. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia 2005; 46: 967– 969. Citing Literature Volume18, Issue12December 2011Pages e151-e151 ReferencesRelatedInformation